Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$54.70 /

+1.095 (+2.04%)

17:27
09/08/20
09/08
17:27
09/08/20
17:27

AstraZeneca's COVID-19 vaccine ph3 study placed on hold, STAT says

STAT's Rebecca Robbins, Adam Feuerstein, and Helen Branswell report that "a large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom... The spokesperson described the pause as 'a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.' The spokesperson also said that the company is 'working to expedite the review of the single event to minimize any potential impact on the trial timeline.'" Reference Link

  • 14

    Sep

AZN AstraZeneca
$54.70 /

+1.095 (+2.04%)

09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results

TODAY'S FREE FLY STORIES

Recommendations
Accenture price target raised to $269 from $247 at Citi » 20:47
09/20/20
09/20
20:47
09/20/20
20:47
ACN

Accenture

$236.07 /

-0.76 (-0.32%)

Citi analyst Ashwin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$236.07 /

-0.76 (-0.32%)

ACN Accenture
$236.07 /

-0.76 (-0.32%)

09/17/20 Stifel
Accenture price target raised to $270 from $236 at Stifel
09/16/20 Morgan Stanley
Accenture price target raised to $250 from $230 at Morgan Stanley
08/17/20 JPMorgan
Accenture price target raised to $256 from $228 at JPMorgan
06/26/20 Susquehanna
Accenture price target raised to $250 from $225 at Susquehanna
ACN Accenture
$236.07 /

-0.76 (-0.32%)

ACN Accenture
$236.07 /

-0.76 (-0.32%)

ACN Accenture
$236.07 /

-0.76 (-0.32%)

ACN Accenture
$236.07 /

-0.76 (-0.32%)

Upgrade
Axcelis upgraded to Buy from Hold at Stifel » 20:46
09/20/20
09/20
20:46
09/20/20
20:46
ACLS

Axcelis

$22.54 /

+0.29 (+1.30%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACLS Axcelis
$22.54 /

+0.29 (+1.30%)

ACLS Axcelis
$22.54 /

+0.29 (+1.30%)

08/12/20 Needham
Axcelis initiated with a Buy at Needham
08/05/20 Stifel
Axcelis price target lowered to $26 from $30 at Stifel
08/05/20 DA Davidson
DA Davidson calls selloff overdone, boosts Axcelis to Buy
08/05/20 DA Davidson
Axcelis upgraded to Buy from Neutral at DA Davidson
ACLS Axcelis
$22.54 /

+0.29 (+1.30%)

Upgrade
Ultra Clean upgraded to Buy from Hold at Stifel » 20:45
09/20/20
09/20
20:45
09/20/20
20:45
UCTT

Ultra Clean

$20.39 /

-0.06 (-0.29%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UCTT Ultra Clean
$20.39 /

-0.06 (-0.29%)

UCTT Ultra Clean
$20.39 /

-0.06 (-0.29%)

08/14/20 Stifel
KLA Corp, ACM likely beneficiaries after Applied Materials earnings, says Stifel
07/30/20 Craig-Hallum
Ultra Clean price target raised to $40 from $35 at Craig-Hallum
04/30/20 Needham
Ultra Clean price target lowered to $26 from $30 at Needham
02/20/20 Craig-Hallum
Ultra Clean price target raised to $35 from $30 at Craig-Hallum
UCTT Ultra Clean
$20.39 /

-0.06 (-0.29%)

UCTT Ultra Clean
$20.39 /

-0.06 (-0.29%)

Upgrade
Ichor Holdings upgraded to Buy from Hold at Stifel » 20:45
09/20/20
09/20
20:45
09/20/20
20:45
ICHR

Ichor Holdings

$21.38 /

-0.4 (-1.84%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ICHR Ichor Holdings
$21.38 /

-0.4 (-1.84%)

08/04/20 B. Riley FBR
Ichor Holdings price target raised to $42 from $33 at B. Riley FBR
08/04/20 Deutsche Bank
Ichor Holdings price target raised to $38 from $32 at Deutsche Bank
06/23/20 DA Davidson
Ichor Holdings upgraded to Buy from Neutral at DA Davidson
06/23/20 DA Davidson
Ichor Holdings upgraded to Buy from Neutral at DA Davidson
ICHR Ichor Holdings
$21.38 /

-0.4 (-1.84%)

Upgrade
KLA Corp. upgraded to Buy from Hold at Stifel » 20:44
09/20/20
09/20
20:44
09/20/20
20:44
KLAC

KLA Corp.

/

+

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

08/14/20 Stifel
KLA Corp, ACM likely beneficiaries after Applied Materials earnings, says Stifel
08/04/20 JPMorgan
KLA Corp. price target raised to $250 from $210 at JPMorgan
08/04/20 Wells Fargo
KLA Corp. price target raised to $200 from $160 at Wells Fargo
08/04/20 Credit Suisse
KLA Corp. price target raised to $240 from $200 at Credit Suisse
KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

Upgrade
Kornit Digital upgraded to Buy from Neutral at Citi » 20:44
09/20/20
09/20
20:44
09/20/20
20:44
KRNT

Kornit Digital

$58.09 /

+1.14 (+2.00%)

, AMZN

Amazon.com

$2,953.50 /

-55.17 (-1.83%)

Citi analyst Jim Suva…

Citi analyst Jim Suva upgraded Kornit Digital (KRNT) to Buy from Neutral with a price target of $70, up from $55. The stock has pulled back materially given its follow-on offering and warrant issue conversion by Amazon (AMZN) which was announced on September 14, Suva tells investors in a research note. In addition, fundamentals have increasingly improved with digital printing on garments and a shift to more localized printing, says the analyst. Suva notes that Kornit's largest customer Amazon has increased its demand for Kornit printers and ink via a higher master purchase agreement which was newly announced at $400M compared $150M previously in the follow-on offering documents. Kornit is now the analyst's top small cap growth stock pick. He sees the next catalyst for the stock as the company's earnings in November.

ShowHide Related Items >><<
KRNT Kornit Digital
$58.09 /

+1.14 (+2.00%)

AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

KRNT Kornit Digital
$58.09 /

+1.14 (+2.00%)

08/19/20 Needham
Kornit Digital price target raised to $67 from $60 at Needham
08/12/20 Needham
Kornit Digital price target raised to $60 from $46 at Needham
06/22/20 Craig-Hallum
Kornit Digital price target raised to $50 from $34 at Craig-Hallum
05/20/20 Craig-Hallum
Kornit Digital price target raised to $34 from $21 at Craig-Hallum
AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

09/18/20 RBC Capital
Amazon.com's logistics network underappreciated by investors, says RBC Capital
09/16/20 Morgan Stanley
FedEx price target raised to $250 from $110 at Morgan Stanley
09/08/20 Goldman Sachs
Goldman sticks with Sell on Apple despite 71% rally since downgrade
09/03/20 Baird
Amazon working to better handle unprecedented seasonal Q4 demand, says Baird
KRNT Kornit Digital
$58.09 /

+1.14 (+2.00%)

AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

  • 17
    Sep
AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

KRNT Kornit Digital
$58.09 /

+1.14 (+2.00%)

AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

AMZN Amazon.com
$2,953.50 /

-55.17 (-1.83%)

Upgrade
Brooks Automation upgraded to Buy from Hold at Stifel » 20:44
09/20/20
09/20
20:44
09/20/20
20:44
BRKS

Brooks Automation

$45.52 /

-0.09 (-0.20%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$45.52 /

-0.09 (-0.20%)

08/04/20 Needham
Brooks Automation upgraded to Buy from Hold at Needham
08/04/20 Needham
Brooks Automation upgraded to Buy from Hold at Needham
07/31/20 B. Riley FBR
Brooks Automation price target raised to $65 from $55 at B. Riley FBR
06/29/20 B. Riley FBR
Brooks Automation price target raised to $55 from $50 at B. Riley FBR
BRKS Brooks Automation
$45.52 /

-0.09 (-0.20%)

BRKS Brooks Automation
$45.52 /

-0.09 (-0.20%)

Upgrade
Lam Research upgraded to Buy from Hold at Stifel » 20:44
09/20/20
09/20
20:44
09/20/20
20:44
LRCX

Lam Research

$307.23 /

+1.34 (+0.44%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

07/30/20 Wells Fargo
Lam Research price target raised to $370 from $270 at Wells Fargo
07/30/20 Credit Suisse
Lam Research price target raised to $450 from $370 at Credit Suisse
07/30/20 Needham
Lam Research price target raised to $400 from $325 at Needham
07/30/20 DA Davidson
Lam Research price target raised to $370 from $270 at DA Davidson
LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

LRCX Lam Research
$307.23 /

+1.34 (+0.44%)

Recommendations
Western Digital named short-term buy idea at Deutsche Bank » 20:42
09/20/20
09/20
20:42
09/20/20
20:42
WDC

Western Digital

$37.21 /

-1.07 (-2.80%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$37.21 /

-1.07 (-2.80%)

WDC Western Digital
$37.21 /

-1.07 (-2.80%)

08/12/20 Deutsche Bank
Micron downgraded to Hold from Buy at Deutsche Bank
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Craig-Hallum
Western Digital downgraded to Hold at Craig-Hallum
08/06/20 Baird
Western Digital price target lowered to $50 from $75 at Baird
WDC Western Digital
$37.21 /

-1.07 (-2.80%)

WDC Western Digital
$37.21 /

-1.07 (-2.80%)

WDC Western Digital
$37.21 /

-1.07 (-2.80%)

WDC Western Digital
$37.21 /

-1.07 (-2.80%)

Recommendations
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi » 20:41
09/20/20
09/20
20:41
09/20/20
20:41
GILD

Gilead

$65.05 /

+0.03 (+0.05%)

, IMMU

Immunomedics

$85.50 /

+0.19 (+0.22%)

Citi analyst Mohit Bansal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
09/15/20 Maxim
Gilead upgraded to Buy from Hold at Maxim
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

20:35 Today Piper Sandler
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 Piper Sandler
Novocure price target raised to $125 from $89 at Piper Sandler
09/15/20
Fly Intel: Top analyst downgrades
GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

  • 29
    Apr
  • 05
    Dec
GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

Initiation
Carrier Global initiated with a Buy at Goldman Sachs » 20:39
09/20/20
09/20
20:39
09/20/20
20:39
CARR

Carrier Global

$30.79 /

+0.12 (+0.39%)

Goldman Sachs analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

09/08/20 Credit Suisse
Carrier Global initiated with a Neutral at Credit Suisse
09/08/20 Credit Suisse
Carrier Global initiated with a Neutral at Credit Suisse
08/13/20 Argus
Carrier Global price target raised to $34 from $28 at Argus
07/31/20 Barclays
Carrier Global price target raised to $29 from $26 at Barclays
CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

CARR Carrier Global
$30.79 /

+0.12 (+0.39%)

Hot Stocks
Fly Intel: Top five weekend stock stories » 20:36
09/20/20
09/20
20:36
09/20/20
20:36
ORCL

Oracle

$59.77 /

-0.43 (-0.71%)

, WMT

Walmart

$135.30 /

-1.39 (-1.02%)

, NVDA

Nvidia

$487.24 /

-11.3 (-2.27%)

, INTC

Intel

$49.89 /

-0.44 (-0.87%)

, TSM

TSMC

$80.21 /

-1.69 (-2.06%)

, GTX

Garrett Motion

$2.01 /

-0.395 (-16.42%)

, T

AT&T

$28.92 /

-0.16 (-0.55%)

, PYPL

PayPal

$176.01 /

+0.25 (+0.14%)

, SQ

Square

$145.07 /

-0.565 (-0.39%)

, ACI

Albertsons

$13.07 /

-0.21 (-1.58%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. President Trump has announced that ByteDance has received tentative approval for an agreement with the U.S. Government to resolve the outstanding issues, which will now include Oracle (ORCL) and Walmart (WMT) together investing to acquire 20% of the newly formed TikTok Global business. As a part of the deal, TikTok is creating a new company called TikTok Global that will be responsible for providing all TikTok services to users in United States and most of the users in the rest of the world. The administration has conditionally approved a landmark deal where Oracle becomes TikTok's secure cloud provider. TikTok Global will be majority owned by American investors, including Oracle and Walmart. TikTok Global will be an independent American company, headquartered in the U.S., with four Americans out of the five member Board of Directors. All the TikTok technology will be in possession of TikTok Global, and comply with U.S. laws and privacy regulations. Data privacy for 100M American TikTok users will be quickly established by moving all American data to Oracle's Generation 2 Cloud data centers. TikTok Global will create more than 25,000 new jobs in the Unites States and TikTok Global will pay more than 5B in new tax dollars to the U.S. Treasury. TikTok Global will have an Initial Public Offering in less than 12 months and be listed on a U.S. Exchange. 2. KPS Capital Partners, through a newly formed affiliate, has entered into a stock and asset purchase agreement with Garrett Motion (GTX), under which KPS will acquire substantially all of the assets of Garrett for approximately $2.1B. Garrett will file a motion with the United States Bankruptcy Court for the Southern District of New York seeking the designation of KPS as the "stalking horse bidder" in a bidding procedures motion in connection with the company's filing of voluntary petitions under Chapter 11 of the Bankruptcy Code. To facilitate the sale process, Garrett has begun a process in the United States to financially restructure through a voluntary Chapter 11 proceeding. The completion of the sale is subject to court approval, among other customary conditions. 3. Nvidia (NVDA) became the largest U.S. chip maker by market value in July, passing industry titan Intel (INTC), but by most measures, Nvidia remains a niche player, Max Cherney wrote in this week's edition of Barron's. For Nvidia to grow into its value, the company has to do something big, and CEO Jensen Huang may have found the answer with his $40B deal for Arm Holdings, the author noted. If there ever was a way to challenge Intel's dominance, Huang may have cracked the code, with a combination of Nvidia's leading graphics processors, Arm's central-processing-unit chips, and its longstanding partnership with TSMC (TSM), which fabricates many of the world's most advanced chips, the report added. 4. Christopher Nolan's "Tenet" earned an estimated $4.7M domestically in its third weekend for a North America total of $36.1M. Internationally, the AT&T (T) subsidiary Warner Bros.' movie grossed another $25M for a foreign tally of $214M and a worldwide total of $250.1M. "Tenet" sports a B CinemaScore and an 74% Rotten Tomatoes. 5. PayPal (PYPL), Square (SQ) and Albertsons (ACI) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

INTC Intel
$49.89 /

-0.44 (-0.87%)

TSM TSMC
$80.21 /

-1.69 (-2.06%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

T AT&T
$28.92 /

-0.16 (-0.55%)

PYPL PayPal
$176.01 /

+0.25 (+0.14%)

SQ Square
$145.07 /

-0.565 (-0.39%)

ACI Albertsons
$13.07 /

-0.21 (-1.58%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
WMT Walmart
$135.30 /

-1.39 (-1.02%)

09/18/20 Cleveland Research
Walmart U.S. sales appear directionally better recently, says Cleveland Research
09/03/20 KeyBanc
Inovalon price target raised to $29 from $24 at KeyBanc
09/03/20 Bernstein
Walmart+ 'a bit rushed,' Walmart still best deal on grocery, says Bernstein
09/02/20 Morgan Stanley
Oak Street deal with Walmart an incremental opportunity, says Morgan Stanley
NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
09/15/20 Needham
Nvidia price target raised to $700 from $600 at Needham
09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
INTC Intel
$49.89 /

-0.44 (-0.87%)

09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
09/08/20 Standpoint Research
Intel upgraded to Buy from Hold at Standpoint Research
TSM TSMC
$80.21 /

-1.69 (-2.06%)

08/28/20 New Street
TSMC initiated with a Buy at New Street
08/24/20 Northland
Northland downgrades AMD to Market Perform on potential Intel, data center risks
07/29/20 Bernstein
ASML downgraded to Market Perform on customer slowdown at Bernstein
07/27/20 Lynx
Might be prudent to take profits on TSMC, wait for pullback, Lynx says
GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

T AT&T
$28.92 /

-0.16 (-0.55%)

08/31/20
Fly Intel: Top five analyst downgrades
08/31/20 Scotiabank
Scotiabank downgrades AT&T to Underperform on spectrum costs, share losses
08/31/20 Scotiabank
AT&T downgraded to Underperform from Sector Perform at Scotiabank
07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
PYPL PayPal
$176.01 /

+0.25 (+0.14%)

09/15/20 Baird
PayPal's Venmo remains favored digital wallet by 'wide margin,' says Baird
08/31/20 Keefe Bruyette
KBW boosts PayPal target to $238, names best idea for second half
08/28/20 Truist
MasterCard price target raised to $415 from $375 at Truist
08/27/20 Mizuho
Mizuho starts PayPal with Buy rating, $285 price target
SQ Square
$145.07 /

-0.565 (-0.39%)

09/16/20 Mizuho
Square lending product could add 10% in gross profit, says Mizuho
08/27/20 Mizuho
Mizuho starts Square with Buy rating, $225 price target
08/26/20 Mizuho
Square initiated with a Buy at Mizuho
08/20/20 Deutsche Bank
Square price target raised to $180 from $140 at Deutsche Bank
ACI Albertsons
$13.07 /

-0.21 (-1.58%)

09/14/20 Morgan Stanley
Kimco Realty upgraded to Overweight on free cash flow at Morgan Stanley
08/11/20
Kimco Realty increased to Overweight from Neutral at Piper Sandler
08/06/20 Credit Suisse
Albertsons assumed with an Outperform at Credit Suisse
07/30/20 MKM Partners
Albertsons initiated with a Neutral at MKM Partners
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

INTC Intel
$49.89 /

-0.44 (-0.87%)

TSM TSMC
$80.21 /

-1.69 (-2.06%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

T AT&T
$28.92 /

-0.16 (-0.55%)

PYPL PayPal
$176.01 /

+0.25 (+0.14%)

SQ Square
$145.07 /

-0.565 (-0.39%)

  • 26
    Jun
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

INTC Intel
$49.89 /

-0.44 (-0.87%)

TSM TSMC
$80.21 /

-1.69 (-2.06%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

T AT&T
$28.92 /

-0.16 (-0.55%)

PYPL PayPal
$176.01 /

+0.25 (+0.14%)

SQ Square
$145.07 /

-0.565 (-0.39%)

ACI Albertsons
$13.07 /

-0.21 (-1.58%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

INTC Intel
$49.89 /

-0.44 (-0.87%)

TSM TSMC
$80.21 /

-1.69 (-2.06%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

T AT&T
$28.92 /

-0.16 (-0.55%)

PYPL PayPal
$176.01 /

+0.25 (+0.14%)

SQ Square
$145.07 /

-0.565 (-0.39%)

ACI Albertsons
$13.07 /

-0.21 (-1.58%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

NVDA Nvidia
$487.24 /

-11.3 (-2.27%)

INTC Intel
$49.89 /

-0.44 (-0.87%)

TSM TSMC
$80.21 /

-1.69 (-2.06%)

T AT&T
$28.92 /

-0.16 (-0.55%)

PYPL PayPal
$176.01 /

+0.25 (+0.14%)

SQ Square
$145.07 /

-0.565 (-0.39%)

ACI Albertsons
$13.07 /

-0.21 (-1.58%)

Recommendations
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler » 20:35
09/20/20
09/20
20:35
09/20/20
20:35
IMMU

Immunomedics

$85.50 /

+0.19 (+0.22%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 Piper Sandler
Novocure price target raised to $125 from $89 at Piper Sandler
09/15/20
Fly Intel: Top analyst downgrades
09/15/20 Guggenheim
Immunomedics downgraded to Neutral from Buy at Guggenheim
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

  • 29
    Apr
  • 05
    Dec
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

Hot Stocks
KPS Capital Partners agrees to acquire Garrett Motion assets for $2.1B » 20:25
09/20/20
09/20
20:25
09/20/20
20:25
GTX

Garrett Motion

$2.01 /

-0.395 (-16.42%)

KPS Capital Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

Hot Stocks
Innovent, Eli Lilly release results of ORIENT-12 study » 20:23
09/20/20
09/20
20:23
09/20/20
20:23
LLY

Eli Lilly

$154.23 /

+1.74 (+1.14%)

Innovent Biologics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

Hot Stocks
Garrett Motion files for Chapter 11 protection » 20:20
09/20/20
09/20
20:20
09/20/20
20:20
GTX

Garrett Motion

$2.01 /

-0.395 (-16.42%)

Garrett Motion announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

GTX Garrett Motion
$2.01 /

-0.395 (-16.42%)

Hot Stocks
Eli Lilly says Verzenio 'significantly' reduced risk of cancer recurrence by 25% » 20:17
09/20/20
09/20
20:17
09/20/20
20:17
LLY

Eli Lilly

$154.23 /

+1.74 (+1.14%)

Eli Lilly announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

Hot Stocks
AstraZeneca, Merck announce final results from Phase III PROfound trial » 20:13
09/20/20
09/20
20:13
09/20/20
20:13
AZN

AstraZeneca

$56.47 /

+0.53 (+0.95%)

, MRK

Merck

$85.82 /

+0.17 (+0.20%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

Hot Stocks
Pieris presents data from monotherapy, atezolizumab combo studies of PRS-343 » 20:11
09/20/20
09/20
20:11
09/20/20
20:11
PIRS

Pieris Pharmaceuticals

$2.96 /

-0.02 (-0.67%)

Pieris Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.96 /

-0.02 (-0.67%)

PIRS Pieris Pharmaceuticals
$2.96 /

-0.02 (-0.67%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
PIRS Pieris Pharmaceuticals
$2.96 /

-0.02 (-0.67%)

PIRS Pieris Pharmaceuticals
$2.96 /

-0.02 (-0.67%)

Hot Stocks
Merck presents new data for vibostolimab, MK-4830, MK-6482 » 20:07
09/20/20
09/20
20:07
09/20/20
20:07
MRK

Merck

$85.82 /

+0.17 (+0.20%)

Merck, known as MSD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

Hot Stocks
MacroGenics presents MGD019 Phase 1 data at ESMO » 20:05
09/20/20
09/20
20:05
09/20/20
20:05
MGNX

MacroGenics

$31.61 /

+0.33 (+1.05%)

MacroGenics has announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

08/03/20 Citi
MacroGenics downgraded to Neutral from Buy at Citi
06/02/20 Citi
MacroGenics price target raised to $25 from $15 at Citi
06/01/20 Guggenheim
Guggenheim upgrades MacroGenics to Buy on pipeline prospects
06/01/20 Guggenheim
MacroGenics upgraded to Buy from Neutral at Guggenheim
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

Hot Stocks
Phase 1 cohort of sotorasib data published in New England Journal of Medicine » 20:02
09/20/20
09/20
20:02
09/20/20
20:02
AMGN

Amgen

$248.01 /

-0.22 (-0.09%)

Amgen has announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

17:14 Today Piper Sandler
Amgen's sotorasib update 'Incrementally positive,' says Piper Sandler
09/18/20 Piper Sandler
Amgen sotosarib Phase 1 data a good news/bad news event, says Piper Sandler
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

Hot Stocks
Blueprint Medicines reports ARROW trial data at ESMO » 19:59
09/20/20
09/20
19:59
09/20/20
19:59
BPMC

Blueprint Medicines

$79.49 /

+1.29 (+1.65%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Blueprint Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$79.49 /

+1.29 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.49 /

+1.29 (+1.65%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
BPMC Blueprint Medicines
$79.49 /

+1.29 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.49 /

+1.29 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Chi-Med highlights surufatinib Phase 3 results in neuroendocrine tumors at ESMO » 19:56
09/20/20
09/20
19:56
09/20/20
19:56
HCM

Hutchison China MediTech

$34.29 /

+0.3 (+0.88%)

Hutchison China MediTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCM Hutchison China MediTech
$34.29 /

+0.3 (+0.88%)

HCM Hutchison China MediTech
$34.29 /

+0.3 (+0.88%)

03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
02/20/20 Goldman Sachs
Hutchison China MediTech initiated with a Buy at Goldman Sachs
HCM Hutchison China MediTech
$34.29 /

+0.3 (+0.88%)

  • 23
    Jan
Hot Stocks
Merck, Eisai present data from two studies evaluating KEYTRUDA plus LENVIMA » 19:53
09/20/20
09/20
19:53
09/20/20
19:53
MRK

Merck

$85.82 /

+0.17 (+0.20%)

Merck, known as MSD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.